Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.19.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2019
Stockholders' Equity Note [Abstract]  
Schedule of changes in options outstanding
    Number
of
Options
    Weighted Average Exercise Price For Share     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value
 
Outstanding and expected to vest at June 30, 2019     1,473,314     $ 5.18       8.6     $ 4,668,153  
Granted     900,000     $ 8.80       9.8     $ 1,305,000  
Outstanding and expected to vest at September 30, 2019     2,373,314     $ 6.55       8.9     $ 9,864,756  
Options exercisable at September 30, 2019     547,481     $ 6.93       7.7     $ 2,899,818  
Schedule of changes in outstanding warrants

    Number of Shares     Weighted Average Exercise Price Per Share  
Outstanding and vested at June 30, 2019     4,429,982     $ 7.12  
Issued     6,250       8.80  
Exercised     (75,000 )     6.00  
Forfeited     (52,470 )     16.00  
Outstanding and vested at September 30, 2019     4,308,762     $ 7.03  
Schedule of stock-based compensation expense

    Three Months Ended
September 30,
2019
    Three Months Ended
September 30,
2018
 
Research and development   $ 73,000     $ 13,400  
General and administrative     684,700       139,400  
Total   $ 757,700     $ 152,800